Correlation Between Ginkgo Bioworks and Prime Medicine,
Can any of the company-specific risk be diversified away by investing in both Ginkgo Bioworks and Prime Medicine, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ginkgo Bioworks and Prime Medicine, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ginkgo Bioworks Holdings and Prime Medicine, Common, you can compare the effects of market volatilities on Ginkgo Bioworks and Prime Medicine, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ginkgo Bioworks with a short position of Prime Medicine,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ginkgo Bioworks and Prime Medicine,.
Diversification Opportunities for Ginkgo Bioworks and Prime Medicine,
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Ginkgo and Prime is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Ginkgo Bioworks Holdings and Prime Medicine, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Medicine, Common and Ginkgo Bioworks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ginkgo Bioworks Holdings are associated (or correlated) with Prime Medicine,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Medicine, Common has no effect on the direction of Ginkgo Bioworks i.e., Ginkgo Bioworks and Prime Medicine, go up and down completely randomly.
Pair Corralation between Ginkgo Bioworks and Prime Medicine,
Considering the 90-day investment horizon Ginkgo Bioworks Holdings is expected to generate 1.17 times more return on investment than Prime Medicine,. However, Ginkgo Bioworks is 1.17 times more volatile than Prime Medicine, Common. It trades about -0.1 of its potential returns per unit of risk. Prime Medicine, Common is currently generating about -0.26 per unit of risk. If you would invest 827.00 in Ginkgo Bioworks Holdings on August 27, 2024 and sell it today you would lose (109.00) from holding Ginkgo Bioworks Holdings or give up 13.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ginkgo Bioworks Holdings vs. Prime Medicine, Common
Performance |
| Timeline |
| Ginkgo Bioworks Holdings |
| Prime Medicine, Common |
Ginkgo Bioworks and Prime Medicine, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ginkgo Bioworks and Prime Medicine,
The main advantage of trading using opposite Ginkgo Bioworks and Prime Medicine, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ginkgo Bioworks position performs unexpectedly, Prime Medicine, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Medicine, will offset losses from the drop in Prime Medicine,'s long position.| Ginkgo Bioworks vs. Eliem Therapeutics | Ginkgo Bioworks vs. HCW Biologics | Ginkgo Bioworks vs. Scpharmaceuticals | Ginkgo Bioworks vs. Milestone Pharmaceuticals |
| Prime Medicine, vs. Beam Therapeutics | Prime Medicine, vs. Caribou Biosciences | Prime Medicine, vs. Intellia Therapeutics | Prime Medicine, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |